

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.20388829 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.03310965 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.93287303 |
| 4 | synaptic vesicle maturation (GO:0016188) | 5.84426167 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.56812263 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.56416776 |
| 7 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.52280258 |
| 8 | * vocalization behavior (GO:0071625) | 5.48867190 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 5.45906617 |
| 10 | glutamate secretion (GO:0014047) | 5.34662134 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.10121240 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.07698724 |
| 13 | protein localization to synapse (GO:0035418) | 4.97222901 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.90102799 |
| 15 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.61290054 |
| 16 | neurotransmitter secretion (GO:0007269) | 4.54998592 |
| 17 | exploration behavior (GO:0035640) | 4.53143392 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 4.52256687 |
| 19 | glutamate receptor signaling pathway (GO:0007215) | 4.48640542 |
| 20 | synaptic transmission, glutamatergic (GO:0035249) | 4.48321827 |
| 21 | neuron cell-cell adhesion (GO:0007158) | 4.39102324 |
| 22 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.36968142 |
| 23 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.35605851 |
| 24 | layer formation in cerebral cortex (GO:0021819) | 4.31098770 |
| 25 | positive regulation of synapse maturation (GO:0090129) | 4.27734613 |
| 26 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.27225198 |
| 27 | neuronal action potential propagation (GO:0019227) | 4.22631672 |
| 28 | cellular potassium ion homeostasis (GO:0030007) | 4.21741244 |
| 29 | neuron-neuron synaptic transmission (GO:0007270) | 4.14277589 |
| 30 | dendritic spine morphogenesis (GO:0060997) | 4.11451628 |
| 31 | long-term memory (GO:0007616) | 4.08851228 |
| 32 | gamma-aminobutyric acid transport (GO:0015812) | 4.05185865 |
| 33 | regulation of synapse structural plasticity (GO:0051823) | 3.99808921 |
| 34 | positive regulation of membrane potential (GO:0045838) | 3.98124038 |
| 35 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.95810509 |
| 36 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.83725702 |
| 37 | regulation of postsynaptic membrane potential (GO:0060078) | 3.80150505 |
| 38 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.74650638 |
| 39 | synaptic vesicle endocytosis (GO:0048488) | 3.73845494 |
| 40 | sodium ion export (GO:0071436) | 3.72963674 |
| 41 | presynaptic membrane organization (GO:0097090) | 3.72080252 |
| 42 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.67807191 |
| 43 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.67332789 |
| 44 | neurotransmitter transport (GO:0006836) | 3.66410802 |
| 45 | proline transport (GO:0015824) | 3.65578221 |
| 46 | cerebellar granule cell differentiation (GO:0021707) | 3.65247195 |
| 47 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.64320296 |
| 48 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.61382076 |
| 49 | regulation of neurotransmitter secretion (GO:0046928) | 3.53383559 |
| 50 | * regulation of synaptic plasticity (GO:0048167) | 3.51961001 |
| 51 | response to pheromone (GO:0019236) | 3.47954364 |
| 52 | postsynaptic membrane organization (GO:0001941) | 3.45072941 |
| 53 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.44383506 |
| 54 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.43696794 |
| 55 | auditory behavior (GO:0031223) | 3.40677802 |
| 56 | regulation of neurotransmitter levels (GO:0001505) | 3.39754654 |
| 57 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.37996288 |
| 58 | neuromuscular process controlling balance (GO:0050885) | 3.36449852 |
| 59 | activation of protein kinase A activity (GO:0034199) | 3.36345072 |
| 60 | regulation of synapse maturation (GO:0090128) | 3.33701565 |
| 61 | neuron recognition (GO:0008038) | 3.32260418 |
| 62 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.31463467 |
| 63 | transmission of nerve impulse (GO:0019226) | 3.31225180 |
| 64 | membrane hyperpolarization (GO:0060081) | 3.28738850 |
| 65 | dendrite morphogenesis (GO:0048813) | 3.27848331 |
| 66 | cochlea development (GO:0090102) | 3.26010026 |
| 67 | positive regulation of neurotransmitter transport (GO:0051590) | 3.24971744 |
| 68 | regulation of neurotransmitter transport (GO:0051588) | 3.24347937 |
| 69 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.22490764 |
| 70 | response to auditory stimulus (GO:0010996) | 3.22387470 |
| 71 | innervation (GO:0060384) | 3.19952527 |
| 72 | membrane depolarization (GO:0051899) | 3.19900429 |
| 73 | positive regulation of dendritic spine development (GO:0060999) | 3.18627641 |
| 74 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.18282965 |
| 75 | * long-term synaptic potentiation (GO:0060291) | 3.17444143 |
| 76 | cell communication by electrical coupling (GO:0010644) | 3.14570813 |
| 77 | regulation of vesicle fusion (GO:0031338) | 3.14055341 |
| 78 | axonal fasciculation (GO:0007413) | 3.13298392 |
| 79 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.12692392 |
| 80 | membrane depolarization during action potential (GO:0086010) | 3.12232066 |
| 81 | dendritic spine organization (GO:0097061) | 3.11387237 |
| 82 | neuromuscular process controlling posture (GO:0050884) | 3.10753849 |
| 83 | regulation of dendritic spine development (GO:0060998) | 3.08794740 |
| 84 | response to histamine (GO:0034776) | 3.07489174 |
| 85 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.06911616 |
| 86 | behavioral defense response (GO:0002209) | 3.04749526 |
| 87 | behavioral fear response (GO:0001662) | 3.04749526 |
| 88 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.04522927 |
| 89 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.04522927 |
| 90 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.04522927 |
| 91 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.04068801 |
| 92 | glycine transport (GO:0015816) | 3.02888262 |
| 93 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.02732380 |
| 94 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.00612600 |
| 95 | * learning (GO:0007612) | 2.99806416 |
| 96 | presynaptic membrane assembly (GO:0097105) | 2.98989469 |
| 97 | prepulse inhibition (GO:0060134) | 2.98299378 |
| 98 | synaptic transmission (GO:0007268) | 2.96751862 |
| 99 | * regulation of synaptic transmission (GO:0050804) | 2.96420830 |
| 100 | behavioral response to cocaine (GO:0048148) | 2.94660745 |
| 101 | * synapse assembly (GO:0007416) | 2.93520003 |
| 102 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.93439151 |
| 103 | regulation of ARF protein signal transduction (GO:0032012) | 2.93265201 |
| 104 | fear response (GO:0042596) | 2.92078865 |
| 105 | * positive regulation of synaptic transmission (GO:0050806) | 2.91249147 |
| 106 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.90875575 |
| 107 | regulation of gene silencing by miRNA (GO:0060964) | 2.90875575 |
| 108 | regulation of gene silencing by RNA (GO:0060966) | 2.90875575 |
| 109 | chemosensory behavior (GO:0007635) | 2.89525024 |
| 110 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.88870226 |
| 111 | limb bud formation (GO:0060174) | 2.85541599 |
| 112 | cilium movement (GO:0003341) | 2.78409760 |
| 113 | nucleobase catabolic process (GO:0046113) | 2.73727022 |
| 114 | regulation of hippo signaling (GO:0035330) | 2.72691528 |
| 115 | startle response (GO:0001964) | 2.72079579 |
| 116 | apical protein localization (GO:0045176) | 2.67653892 |
| 117 | behavioral response to nicotine (GO:0035095) | 2.66268343 |
| 118 | positive regulation of synapse assembly (GO:0051965) | 2.63066559 |
| 119 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.60501333 |
| 120 | negative regulation of sodium ion transport (GO:0010766) | 2.56757821 |
| 121 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.56731998 |
| 122 | * synapse organization (GO:0050808) | 2.52256469 |
| 123 | epithelial cilium movement (GO:0003351) | 2.51113615 |
| 124 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.49488329 |
| 125 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.48776507 |
| 126 | mechanosensory behavior (GO:0007638) | 2.48149869 |
| 127 | cell migration in hindbrain (GO:0021535) | 2.45716149 |
| 128 | neuromuscular synaptic transmission (GO:0007274) | 2.44100235 |
| 129 | regulation of neuron migration (GO:2001222) | 2.43065249 |
| 130 | cellular sodium ion homeostasis (GO:0006883) | 2.42774805 |
| 131 | regulation of synapse assembly (GO:0051963) | 2.40443469 |
| 132 | axonemal dynein complex assembly (GO:0070286) | 2.39397168 |
| 133 | central nervous system neuron axonogenesis (GO:0021955) | 2.37063246 |
| 134 | neurofilament cytoskeleton organization (GO:0060052) | 2.36296046 |
| 135 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.32606333 |
| 136 | nephron epithelium morphogenesis (GO:0072088) | 2.32446141 |
| 137 | nephron tubule morphogenesis (GO:0072078) | 2.32446141 |
| 138 | neuronal ion channel clustering (GO:0045161) | 2.32048377 |
| 139 | negative regulation of dendrite development (GO:2000171) | 2.31951638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.79639487 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.50093939 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.01419370 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.00504051 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.96881927 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.73361777 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.69737395 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.69737395 |
| 9 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.68127352 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.58329708 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.51763743 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48487998 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.46367393 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.45790775 |
| 15 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.43926324 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.38416382 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.34103849 |
| 18 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.25531037 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.23619302 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.22822257 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.16327665 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.13680184 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.05229924 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.03157710 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.95801258 |
| 26 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.92481285 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.91966349 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.82710253 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.82408878 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.72364360 |
| 31 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.70410652 |
| 32 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.65855264 |
| 33 | VDR_22108803_ChIP-Seq_LS180_Human | 1.65292695 |
| 34 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.61839315 |
| 35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.59831840 |
| 36 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.58903072 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.54701509 |
| 38 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.52465228 |
| 39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.47180674 |
| 40 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.44006048 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.42692995 |
| 42 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.40789480 |
| 43 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.37322581 |
| 44 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.31970775 |
| 45 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.30769739 |
| 46 | FUS_26573619_Chip-Seq_HEK293_Human | 1.30027579 |
| 47 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29789126 |
| 48 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29665089 |
| 49 | P300_19829295_ChIP-Seq_ESCs_Human | 1.28244914 |
| 50 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28153346 |
| 51 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.27470028 |
| 52 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26305415 |
| 53 | AR_19668381_ChIP-Seq_PC3_Human | 1.25752275 |
| 54 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.23938813 |
| 55 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.23618035 |
| 56 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.23424518 |
| 57 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23217697 |
| 58 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.22952087 |
| 59 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.22797486 |
| 60 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22762480 |
| 61 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.21589129 |
| 62 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.20016936 |
| 63 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19673346 |
| 64 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18126181 |
| 65 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.17749448 |
| 66 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.17576402 |
| 67 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.16776405 |
| 68 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15948280 |
| 69 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15212573 |
| 70 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15017092 |
| 71 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14569881 |
| 72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.13027866 |
| 73 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11632825 |
| 74 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.10879259 |
| 75 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.10161017 |
| 76 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10002940 |
| 77 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09444845 |
| 78 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09127451 |
| 79 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08682249 |
| 80 | KDM2B_26808549_Chip-Seq_K562_Human | 1.06917974 |
| 81 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.06747670 |
| 82 | EWS_26573619_Chip-Seq_HEK293_Human | 1.04756209 |
| 83 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.03959927 |
| 84 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03463372 |
| 85 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02683814 |
| 86 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.02345182 |
| 87 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.01389265 |
| 88 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01326777 |
| 89 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01299537 |
| 90 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.01041234 |
| 91 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00738319 |
| 92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00703759 |
| 93 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.00508069 |
| 94 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.00358703 |
| 95 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.00216702 |
| 96 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00179899 |
| 97 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.99793237 |
| 98 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.98539787 |
| 99 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98467122 |
| 100 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98152294 |
| 101 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.98028613 |
| 102 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.98028613 |
| 103 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96502823 |
| 104 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96071002 |
| 105 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96071002 |
| 106 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.96038927 |
| 107 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95335825 |
| 108 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.94021184 |
| 109 | TP53_16413492_ChIP-PET_HCT116_Human | 0.93316953 |
| 110 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91067291 |
| 111 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.90685901 |
| 112 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90081762 |
| 113 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89964880 |
| 114 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.89475573 |
| 115 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.86777412 |
| 116 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.85852198 |
| 117 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.84248157 |
| 118 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.83921281 |
| 119 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.83543820 |
| 120 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.83329734 |
| 121 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.82905474 |
| 122 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.82777704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.83507789 |
| 2 | MP0003880_abnormal_central_pattern | 4.56369658 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.26307807 |
| 4 | MP0004270_analgesia | 3.65560908 |
| 5 | MP0009745_abnormal_behavioral_response | 3.47052566 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.39403175 |
| 7 | MP0009046_muscle_twitch | 3.33653632 |
| 8 | MP0002064_seizures | 3.18310025 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.94548286 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.88077022 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.85973021 |
| 12 | MP0001486_abnormal_startle_reflex | 2.68415429 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.62375191 |
| 14 | MP0002822_catalepsy | 2.62016458 |
| 15 | MP0002272_abnormal_nervous_system | 2.59940774 |
| 16 | MP0000566_synostosis | 2.37791308 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.36775926 |
| 18 | MP0002736_abnormal_nociception_after | 2.22056903 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.19913912 |
| 20 | MP0002735_abnormal_chemical_nociception | 2.11121051 |
| 21 | MP0003879_abnormal_hair_cell | 2.08097295 |
| 22 | MP0008569_lethality_at_weaning | 2.04685940 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 2.03656569 |
| 24 | MP0002067_abnormal_sensory_capabilities | 2.02923687 |
| 25 | MP0002184_abnormal_innervation | 1.89207920 |
| 26 | MP0002557_abnormal_social/conspecific_i | 1.84446977 |
| 27 | MP0001984_abnormal_olfaction | 1.83884492 |
| 28 | MP0002733_abnormal_thermal_nociception | 1.83332933 |
| 29 | MP0001970_abnormal_pain_threshold | 1.80155810 |
| 30 | MP0003329_amyloid_beta_deposits | 1.74975982 |
| 31 | MP0000778_abnormal_nervous_system | 1.73523133 |
| 32 | MP0004811_abnormal_neuron_physiology | 1.71528467 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.71387263 |
| 34 | MP0004924_abnormal_behavior | 1.71387263 |
| 35 | MP0002909_abnormal_adrenal_gland | 1.65895261 |
| 36 | MP0004858_abnormal_nervous_system | 1.65265345 |
| 37 | MP0004133_heterotaxia | 1.65195866 |
| 38 | MP0004885_abnormal_endolymph | 1.64952911 |
| 39 | MP0005646_abnormal_pituitary_gland | 1.63514031 |
| 40 | MP0000955_abnormal_spinal_cord | 1.45671736 |
| 41 | MP0006276_abnormal_autonomic_nervous | 1.45086776 |
| 42 | MP0001502_abnormal_circadian_rhythm | 1.42317723 |
| 43 | MP0002066_abnormal_motor_capabilities/c | 1.40820566 |
| 44 | MP0003890_abnormal_embryonic-extraembry | 1.40313970 |
| 45 | MP0002882_abnormal_neuron_morphology | 1.39749515 |
| 46 | MP0003123_paternal_imprinting | 1.35831010 |
| 47 | MP0005645_abnormal_hypothalamus_physiol | 1.34780652 |
| 48 | MP0003633_abnormal_nervous_system | 1.34175782 |
| 49 | MP0008875_abnormal_xenobiotic_pharmacok | 1.32365821 |
| 50 | MP0005551_abnormal_eye_electrophysiolog | 1.25080533 |
| 51 | MP0003121_genomic_imprinting | 1.22516411 |
| 52 | MP0008877_abnormal_DNA_methylation | 1.22423399 |
| 53 | MP0003787_abnormal_imprinting | 1.21589318 |
| 54 | MP0004142_abnormal_muscle_tone | 1.19403044 |
| 55 | MP0000579_abnormal_nail_morphology | 1.14345684 |
| 56 | MP0003631_nervous_system_phenotype | 1.13605400 |
| 57 | MP0000569_abnormal_digit_pigmentation | 1.13049824 |
| 58 | MP0008872_abnormal_physiological_respon | 1.12465975 |
| 59 | MP0002152_abnormal_brain_morphology | 1.10822793 |
| 60 | MP0002653_abnormal_ependyma_morphology | 1.09133006 |
| 61 | MP0004742_abnormal_vestibular_system | 1.07628838 |
| 62 | MP0003941_abnormal_skin_development | 1.07625791 |
| 63 | MP0001346_abnormal_lacrimal_gland | 1.05803042 |
| 64 | MP0003938_abnormal_ear_development | 1.02486233 |
| 65 | MP0003195_calcinosis | 1.01378817 |
| 66 | MP0002069_abnormal_eating/drinking_beha | 1.00865583 |
| 67 | MP0004145_abnormal_muscle_electrophysio | 1.00779514 |
| 68 | MP0010386_abnormal_urinary_bladder | 1.00707596 |
| 69 | MP0003119_abnormal_digestive_system | 1.00081242 |
| 70 | MP0001529_abnormal_vocalization | 0.98823745 |
| 71 | MP0001188_hyperpigmentation | 0.98628806 |
| 72 | MP0001177_atelectasis | 0.98302927 |
| 73 | MP0002229_neurodegeneration | 0.98255628 |
| 74 | MP0001905_abnormal_dopamine_level | 0.95606068 |
| 75 | MP0008874_decreased_physiological_sensi | 0.95130914 |
| 76 | MP0002102_abnormal_ear_morphology | 0.94351495 |
| 77 | MP0001299_abnormal_eye_distance/ | 0.92942440 |
| 78 | MP0002249_abnormal_larynx_morphology | 0.92017167 |
| 79 | MP0003937_abnormal_limbs/digits/tail_de | 0.91283991 |
| 80 | MP0002751_abnormal_autonomic_nervous | 0.89735081 |
| 81 | MP0001963_abnormal_hearing_physiology | 0.87103976 |
| 82 | MP0000383_abnormal_hair_follicle | 0.86726700 |
| 83 | MP0008961_abnormal_basal_metabolism | 0.85786489 |
| 84 | MP0002090_abnormal_vision | 0.85277978 |
| 85 | MP0003632_abnormal_nervous_system | 0.85024126 |
| 86 | MP0003690_abnormal_glial_cell | 0.84955647 |
| 87 | MP0002938_white_spotting | 0.84290682 |
| 88 | MP0005535_abnormal_body_temperature | 0.84096070 |
| 89 | MP0003075_altered_response_to | 0.83896341 |
| 90 | MP0006292_abnormal_olfactory_placode | 0.83596262 |
| 91 | MP0001485_abnormal_pinna_reflex | 0.83414212 |
| 92 | MP0009703_decreased_birth_body | 0.83337498 |
| 93 | MP0004085_abnormal_heartbeat | 0.81569043 |
| 94 | MP0002089_abnormal_postnatal_growth/wei | 0.81491878 |
| 95 | MP0000534_abnormal_ureter_morphology | 0.80742078 |
| 96 | MP0003122_maternal_imprinting | 0.79728633 |
| 97 | MP0003942_abnormal_urinary_system | 0.78671172 |
| 98 | MP0002233_abnormal_nose_morphology | 0.76639851 |
| 99 | MP0000751_myopathy | 0.76372149 |
| 100 | MP0000604_amyloidosis | 0.76245050 |
| 101 | MP0004043_abnormal_pH_regulation | 0.75717310 |
| 102 | MP0002752_abnormal_somatic_nervous | 0.75673435 |
| 103 | MP0009672_abnormal_birth_weight | 0.75593538 |
| 104 | MP0000631_abnormal_neuroendocrine_gland | 0.74022784 |
| 105 | MP0005499_abnormal_olfactory_system | 0.73950334 |
| 106 | MP0005394_taste/olfaction_phenotype | 0.73950334 |
| 107 | MP0004233_abnormal_muscle_weight | 0.72315724 |
| 108 | MP0003634_abnormal_glial_cell | 0.71919199 |
| 109 | MP0001666_abnormal_nutrient_absorption | 0.71239078 |
| 110 | MP0003755_abnormal_palate_morphology | 0.70772522 |
| 111 | MP0003283_abnormal_digestive_organ | 0.70183186 |
| 112 | MP0001664_abnormal_digestion | 0.67886298 |
| 113 | MP0002234_abnormal_pharynx_morphology | 0.66027001 |
| 114 | MP0005377_hearing/vestibular/ear_phenot | 0.65478081 |
| 115 | MP0003137_abnormal_impulse_conducting | 0.62372548 |
| 116 | MP0002638_abnormal_pupillary_reflex | 0.62330153 |
| 117 | MP0002876_abnormal_thyroid_physiology | 0.61165261 |
| 118 | MP0005187_abnormal_penis_morphology | 0.61127381 |
| 119 | MP0000920_abnormal_myelination | 0.59762368 |
| 120 | MP0000013_abnormal_adipose_tissue | 0.59046897 |
| 121 | MP0004215_abnormal_myocardial_fiber | 0.58903464 |
| 122 | MP0004484_altered_response_of | 0.57825709 |
| 123 | MP0005167_abnormal_blood-brain_barrier | 0.56634914 |
| 124 | MP0010769_abnormal_survival | 0.54897672 |
| 125 | MP0003861_abnormal_nervous_system | 0.54126686 |
| 126 | MP0002082_postnatal_lethality | 0.53401804 |
| 127 | MP0010770_preweaning_lethality | 0.53401804 |
| 128 | MP0003045_fibrosis | 0.52879096 |
| 129 | MP0000026_abnormal_inner_ear | 0.52052481 |
| 130 | MP0010768_mortality/aging | 0.51423091 |
| 131 | MP0010234_abnormal_vibrissa_follicle | 0.49285575 |
| 132 | MP0001943_abnormal_respiration | 0.49255120 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.62103972 |
| 2 | Myokymia (HP:0002411) | 6.77066052 |
| 3 | Focal seizures (HP:0007359) | 5.83053485 |
| 4 | Visual hallucinations (HP:0002367) | 5.36885284 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.17533984 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 4.99493664 |
| 7 | Febrile seizures (HP:0002373) | 4.69693370 |
| 8 | Atonic seizures (HP:0010819) | 4.45503432 |
| 9 | Action tremor (HP:0002345) | 4.42994023 |
| 10 | Absence seizures (HP:0002121) | 4.37568569 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 3.93598536 |
| 12 | Dialeptic seizures (HP:0011146) | 3.92381755 |
| 13 | Gaze-evoked nystagmus (HP:0000640) | 3.92033706 |
| 14 | Broad-based gait (HP:0002136) | 3.86432163 |
| 15 | Hyperventilation (HP:0002883) | 3.64924120 |
| 16 | Poor eye contact (HP:0000817) | 3.61454049 |
| 17 | Dysdiadochokinesis (HP:0002075) | 3.54863786 |
| 18 | Genetic anticipation (HP:0003743) | 3.35641301 |
| 19 | Impaired social interactions (HP:0000735) | 3.31758152 |
| 20 | Abnormal social behavior (HP:0012433) | 3.31758152 |
| 21 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.23565948 |
| 22 | Dysmetria (HP:0001310) | 3.23120525 |
| 23 | Depression (HP:0000716) | 3.21702812 |
| 24 | Supranuclear gaze palsy (HP:0000605) | 3.20562990 |
| 25 | Impaired smooth pursuit (HP:0007772) | 3.13017851 |
| 26 | Abnormality of the lower motor neuron (HP:0002366) | 3.11319223 |
| 27 | Ankle clonus (HP:0011448) | 3.10434690 |
| 28 | Truncal ataxia (HP:0002078) | 3.03965152 |
| 29 | Anxiety (HP:0000739) | 3.03853311 |
| 30 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.01760303 |
| 31 | Postural instability (HP:0002172) | 3.01605066 |
| 32 | Bronchomalacia (HP:0002780) | 2.98446112 |
| 33 | Dysmetric saccades (HP:0000641) | 2.93574774 |
| 34 | Scanning speech (HP:0002168) | 2.91587635 |
| 35 | Abnormal eating behavior (HP:0100738) | 2.91413146 |
| 36 | Mutism (HP:0002300) | 2.87982444 |
| 37 | Amblyopia (HP:0000646) | 2.87465351 |
| 38 | Abnormality of the labia minora (HP:0012880) | 2.84358602 |
| 39 | Hemiplegia (HP:0002301) | 2.82165148 |
| 40 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.80340967 |
| 41 | Excessive salivation (HP:0003781) | 2.80007113 |
| 42 | Drooling (HP:0002307) | 2.80007113 |
| 43 | Hemiparesis (HP:0001269) | 2.79222341 |
| 44 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.78237833 |
| 45 | Sleep apnea (HP:0010535) | 2.76485678 |
| 46 | Torticollis (HP:0000473) | 2.74868292 |
| 47 | Intention tremor (HP:0002080) | 2.73662446 |
| 48 | Status epilepticus (HP:0002133) | 2.73172428 |
| 49 | Epileptiform EEG discharges (HP:0011182) | 2.65649620 |
| 50 | Focal dystonia (HP:0004373) | 2.59350575 |
| 51 | Stereotypic behavior (HP:0000733) | 2.56162420 |
| 52 | Papilledema (HP:0001085) | 2.56154827 |
| 53 | Abnormality of binocular vision (HP:0011514) | 2.55197819 |
| 54 | Diplopia (HP:0000651) | 2.55197819 |
| 55 | EEG with generalized epileptiform discharges (HP:0011198) | 2.53122428 |
| 56 | Hepatoblastoma (HP:0002884) | 2.52667868 |
| 57 | Abnormal ciliary motility (HP:0012262) | 2.51797755 |
| 58 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.47909228 |
| 59 | Ventricular fibrillation (HP:0001663) | 2.45140907 |
| 60 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.43935614 |
| 61 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.43935614 |
| 62 | Urinary urgency (HP:0000012) | 2.43146399 |
| 63 | Spastic gait (HP:0002064) | 2.42982365 |
| 64 | True hermaphroditism (HP:0010459) | 2.40787582 |
| 65 | Nephronophthisis (HP:0000090) | 2.36183900 |
| 66 | Bradykinesia (HP:0002067) | 2.35875148 |
| 67 | Cerebral inclusion bodies (HP:0100314) | 2.35003145 |
| 68 | Impaired vibratory sensation (HP:0002495) | 2.34460501 |
| 69 | Absent speech (HP:0001344) | 2.34409981 |
| 70 | Agitation (HP:0000713) | 2.32986843 |
| 71 | Hypsarrhythmia (HP:0002521) | 2.32589073 |
| 72 | Neurofibrillary tangles (HP:0002185) | 2.32183135 |
| 73 | Molar tooth sign on MRI (HP:0002419) | 2.27241538 |
| 74 | Abnormality of midbrain morphology (HP:0002418) | 2.27241538 |
| 75 | Craniofacial dystonia (HP:0012179) | 2.26017835 |
| 76 | Fetal akinesia sequence (HP:0001989) | 2.25756351 |
| 77 | Rhinitis (HP:0012384) | 2.21263169 |
| 78 | Chronic bronchitis (HP:0004469) | 2.20485181 |
| 79 | Gait imbalance (HP:0002141) | 2.18457054 |
| 80 | Megalencephaly (HP:0001355) | 2.17756324 |
| 81 | Progressive inability to walk (HP:0002505) | 2.15925299 |
| 82 | Pancreatic cysts (HP:0001737) | 2.14297721 |
| 83 | Labial hypoplasia (HP:0000066) | 2.13215375 |
| 84 | Obstructive sleep apnea (HP:0002870) | 2.12676543 |
| 85 | Generalized myoclonic seizures (HP:0002123) | 2.11153831 |
| 86 | Abnormality of the corticospinal tract (HP:0002492) | 2.10723296 |
| 87 | Abnormality of the renal medulla (HP:0100957) | 2.10657609 |
| 88 | Cystic liver disease (HP:0006706) | 2.10199480 |
| 89 | Pancreatic fibrosis (HP:0100732) | 2.09059135 |
| 90 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.06921491 |
| 91 | Annular pancreas (HP:0001734) | 2.06829848 |
| 92 | Vaginal atresia (HP:0000148) | 2.06788866 |
| 93 | Genital tract atresia (HP:0001827) | 2.05070425 |
| 94 | Gait ataxia (HP:0002066) | 2.03807290 |
| 95 | Incomplete penetrance (HP:0003829) | 2.02318151 |
| 96 | Alacrima (HP:0000522) | 2.02171214 |
| 97 | Lissencephaly (HP:0001339) | 1.99904517 |
| 98 | Inability to walk (HP:0002540) | 1.99035829 |
| 99 | Polyphagia (HP:0002591) | 1.97561227 |
| 100 | Abnormality of saccadic eye movements (HP:0000570) | 1.97482978 |
| 101 | Blue irides (HP:0000635) | 1.97192821 |
| 102 | Insidious onset (HP:0003587) | 1.96961001 |
| 103 | Termporal pattern (HP:0011008) | 1.96961001 |
| 104 | Lower limb muscle weakness (HP:0007340) | 1.96073609 |
| 105 | Scrotal hypoplasia (HP:0000046) | 1.95613630 |
| 106 | Pointed chin (HP:0000307) | 1.94891333 |
| 107 | Hypoplastic female external genitalia (HP:0012815) | 1.89822724 |
| 108 | Hypoplastic labia majora (HP:0000059) | 1.88970604 |
| 109 | Amyotrophic lateral sclerosis (HP:0007354) | 1.88116265 |
| 110 | Limb dystonia (HP:0002451) | 1.87428042 |
| 111 | Abnormality of salivation (HP:0100755) | 1.85144196 |
| 112 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.84403972 |
| 113 | Type II lissencephaly (HP:0007260) | 1.82714578 |
| 114 | Lower limb asymmetry (HP:0100559) | 1.80553576 |
| 115 | Clonus (HP:0002169) | 1.80541989 |
| 116 | Insomnia (HP:0100785) | 1.79908875 |
| 117 | Chronic hepatic failure (HP:0100626) | 1.79416644 |
| 118 | Medial flaring of the eyebrow (HP:0010747) | 1.79165919 |
| 119 | Psychosis (HP:0000709) | 1.77633068 |
| 120 | Morphological abnormality of the middle ear (HP:0008609) | 1.76539544 |
| 121 | Inappropriate behavior (HP:0000719) | 1.75087246 |
| 122 | Gastroesophageal reflux (HP:0002020) | 1.74722170 |
| 123 | Tetraplegia (HP:0002445) | 1.74660635 |
| 124 | Abnormal EKG (HP:0003115) | 1.74638996 |
| 125 | Congenital primary aphakia (HP:0007707) | 1.74135882 |
| 126 | Protruding tongue (HP:0010808) | 1.73934769 |
| 127 | Limb ataxia (HP:0002070) | 1.73821307 |
| 128 | Tubular atrophy (HP:0000092) | 1.72766605 |
| 129 | Cutaneous finger syndactyly (HP:0010554) | 1.71832446 |
| 130 | Bundle branch block (HP:0011710) | 1.71724009 |
| 131 | Neuronal loss in central nervous system (HP:0002529) | 1.70824027 |
| 132 | Clumsiness (HP:0002312) | 1.69786137 |
| 133 | Rigidity (HP:0002063) | 1.68953618 |
| 134 | Abnormality of macular pigmentation (HP:0008002) | 1.67491187 |
| 135 | Abnormality of the pubic bones (HP:0003172) | 1.67401365 |
| 136 | Central scotoma (HP:0000603) | 1.67104152 |
| 137 | Poor coordination (HP:0002370) | 1.66920603 |
| 138 | Absent/shortened dynein arms (HP:0200106) | 1.66471532 |
| 139 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.66471532 |
| 140 | Hyperglycinuria (HP:0003108) | 1.65820711 |
| 141 | Abnormality of the labia majora (HP:0012881) | 1.64129165 |
| 142 | Postural tremor (HP:0002174) | 1.63634222 |
| 143 | Increased circulating renin level (HP:0000848) | 1.63566909 |
| 144 | Choanal stenosis (HP:0000452) | 1.59491696 |
| 145 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.58908012 |
| 146 | Nephrogenic diabetes insipidus (HP:0009806) | 1.58758816 |
| 147 | Decreased lacrimation (HP:0000633) | 1.56968762 |
| 148 | Cerebellar dysplasia (HP:0007033) | 1.56755680 |
| 149 | Bifid scrotum (HP:0000048) | 1.55160094 |
| 150 | Specific learning disability (HP:0001328) | 1.53247148 |
| 151 | Optic nerve hypoplasia (HP:0000609) | 1.51730619 |
| 152 | Aqueductal stenosis (HP:0002410) | 1.51549373 |
| 153 | Tented upper lip vermilion (HP:0010804) | 1.51214304 |
| 154 | Cupped ear (HP:0000378) | 1.49686893 |
| 155 | Tracheomalacia (HP:0002779) | 1.49342596 |
| 156 | Concave nail (HP:0001598) | 1.49088610 |
| 157 | Midline defect of the nose (HP:0004122) | 1.48800958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.31078586 |
| 2 | EPHA4 | 4.24335333 |
| 3 | MAP3K9 | 3.64088438 |
| 4 | MARK1 | 3.16628255 |
| 5 | DAPK2 | 3.02950344 |
| 6 | MAP3K4 | 3.02383749 |
| 7 | MINK1 | 2.67021659 |
| 8 | MAP2K7 | 2.53012992 |
| 9 | PAK6 | 2.41939805 |
| 10 | FRK | 2.24271723 |
| 11 | MAPK15 | 2.21744513 |
| 12 | NTRK2 | 2.20817086 |
| 13 | MAP2K4 | 2.02023849 |
| 14 | CAMKK1 | 1.98706585 |
| 15 | PRKD3 | 1.98299200 |
| 16 | CASK | 1.96637416 |
| 17 | CAMK1D | 1.82084498 |
| 18 | SIK2 | 1.79614830 |
| 19 | DAPK1 | 1.72831470 |
| 20 | KSR2 | 1.72366596 |
| 21 | MAP3K12 | 1.71828310 |
| 22 | STK38 | 1.67394102 |
| 23 | RIPK4 | 1.59013656 |
| 24 | BCR | 1.56505148 |
| 25 | PRPF4B | 1.54503097 |
| 26 | CDK5 | 1.53239665 |
| 27 | NTRK1 | 1.51830738 |
| 28 | KSR1 | 1.50900494 |
| 29 | TNIK | 1.48098777 |
| 30 | PLK2 | 1.35927341 |
| 31 | EPHA2 | 1.32392217 |
| 32 | CAMKK2 | 1.30611607 |
| 33 | PRKCG | 1.29829327 |
| 34 | CDK19 | 1.29148169 |
| 35 | STK39 | 1.29109720 |
| 36 | DYRK2 | 1.28819859 |
| 37 | MAPK13 | 1.27203184 |
| 38 | LATS1 | 1.26683105 |
| 39 | GRK5 | 1.26272717 |
| 40 | PKN2 | 1.22114806 |
| 41 | WNK4 | 1.21648280 |
| 42 | PNCK | 1.21530275 |
| 43 | TYRO3 | 1.16074482 |
| 44 | CAMK1 | 1.13991113 |
| 45 | MAP4K2 | 1.09359792 |
| 46 | RIPK1 | 1.06165637 |
| 47 | SGK223 | 1.04252062 |
| 48 | SGK494 | 1.04252062 |
| 49 | MKNK2 | 1.01668353 |
| 50 | SIK3 | 0.99125508 |
| 51 | TAOK1 | 0.98498284 |
| 52 | STK11 | 0.98462208 |
| 53 | FES | 0.97179660 |
| 54 | CAMK2A | 0.96653367 |
| 55 | SGK2 | 0.95373248 |
| 56 | MAP3K13 | 0.95125767 |
| 57 | PIK3CA | 0.94461230 |
| 58 | MAP3K2 | 0.94090682 |
| 59 | GRK1 | 0.92871222 |
| 60 | TRIM28 | 0.92383298 |
| 61 | OXSR1 | 0.91136516 |
| 62 | MARK2 | 0.90370557 |
| 63 | PHKG2 | 0.89841329 |
| 64 | PHKG1 | 0.89841329 |
| 65 | TRIB3 | 0.86910360 |
| 66 | UHMK1 | 0.86512009 |
| 67 | CDK18 | 0.86444202 |
| 68 | LATS2 | 0.86347989 |
| 69 | CDK15 | 0.84611146 |
| 70 | DYRK1A | 0.82630514 |
| 71 | SGK3 | 0.81470226 |
| 72 | PRKCH | 0.80567353 |
| 73 | STK38L | 0.80272378 |
| 74 | CAMK1G | 0.79856480 |
| 75 | PAK3 | 0.78118523 |
| 76 | BMPR1B | 0.78041493 |
| 77 | ARAF | 0.77556949 |
| 78 | CAMK2B | 0.77441371 |
| 79 | PINK1 | 0.77288536 |
| 80 | CDK14 | 0.76336551 |
| 81 | NUAK1 | 0.74814325 |
| 82 | PTK2B | 0.74810427 |
| 83 | SGK1 | 0.74250902 |
| 84 | CDK12 | 0.74219742 |
| 85 | INSRR | 0.73602190 |
| 86 | TSSK6 | 0.72903020 |
| 87 | RET | 0.72531861 |
| 88 | CDK11A | 0.72478934 |
| 89 | CDK3 | 0.70885418 |
| 90 | ERBB2 | 0.70650630 |
| 91 | ADRBK2 | 0.65997714 |
| 92 | CAMK4 | 0.65180059 |
| 93 | CSNK1G2 | 0.63513504 |
| 94 | MAP3K7 | 0.63410415 |
| 95 | PRKCZ | 0.61975575 |
| 96 | WNK3 | 0.61330856 |
| 97 | PDK1 | 0.61317696 |
| 98 | BMPR2 | 0.60572537 |
| 99 | CSNK1A1L | 0.60540346 |
| 100 | ALK | 0.59706007 |
| 101 | LMTK2 | 0.57450480 |
| 102 | * CSNK1E | 0.56936364 |
| 103 | RAF1 | 0.56067618 |
| 104 | TNK2 | 0.55507173 |
| 105 | PDPK1 | 0.52599803 |
| 106 | CDC42BPA | 0.52593785 |
| 107 | WNK1 | 0.50809423 |
| 108 | * RPS6KA3 | 0.50796626 |
| 109 | FGFR1 | 0.50404936 |
| 110 | PRKAA1 | 0.50261290 |
| 111 | FGFR2 | 0.49158249 |
| 112 | FER | 0.48533812 |
| 113 | ICK | 0.47938662 |
| 114 | ZAK | 0.47380114 |
| 115 | PRKCI | 0.46823693 |
| 116 | MAPK8 | 0.46713946 |
| 117 | FYN | 0.46660427 |
| 118 | CSNK1G1 | 0.45678899 |
| 119 | PRKCE | 0.45672690 |
| 120 | CSNK1A1 | 0.45356510 |
| 121 | CAMK2G | 0.44955603 |
| 122 | GSK3B | 0.44925548 |
| 123 | MAP3K6 | 0.44858240 |
| 124 | CCNB1 | 0.44114866 |
| 125 | CSNK1D | 0.43373584 |
| 126 | NEK6 | 0.43029095 |
| 127 | CAMK2D | 0.42599691 |
| 128 | MAPK10 | 0.41559890 |
| 129 | MAP3K1 | 0.39684860 |
| 130 | NEK1 | 0.38536537 |
| 131 | NME1 | 0.37497118 |
| 132 | AKT3 | 0.36793736 |
| 133 | DAPK3 | 0.36210732 |
| 134 | MAPK12 | 0.34758234 |
| 135 | BRSK1 | 0.32671681 |
| 136 | PRKCB | 0.32022132 |
| 137 | FGR | 0.31756305 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.96774798 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.27932192 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.76332176 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.75791445 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.75447421 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.67985421 |
| 7 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.62579336 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.59175088 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.51977376 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.36440140 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.23621423 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.15665889 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.04885166 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.03610340 |
| 15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.92372588 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.90241103 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.84808291 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.80917918 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.67463983 |
| 20 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.64408307 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.61105449 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.58830608 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.58335163 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.58319043 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.57744712 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.50971244 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.50137746 |
| 28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.48757403 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.46647556 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.38070105 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.34909563 |
| 32 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.27138960 |
| 33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26119691 |
| 34 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26061515 |
| 35 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.25046001 |
| 36 | Gap junction_Homo sapiens_hsa04540 | 1.24727944 |
| 37 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.24551992 |
| 38 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.21341570 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.17744920 |
| 40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14612811 |
| 41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.14332899 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.14175563 |
| 43 | Tight junction_Homo sapiens_hsa04530 | 1.12457071 |
| 44 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.08274477 |
| 45 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.07969394 |
| 46 | Lysine degradation_Homo sapiens_hsa00310 | 1.07030307 |
| 47 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.03922842 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03202827 |
| 49 | Axon guidance_Homo sapiens_hsa04360 | 1.03114823 |
| 50 | Glioma_Homo sapiens_hsa05214 | 1.01509744 |
| 51 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99506170 |
| 52 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.98075241 |
| 53 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.96981465 |
| 54 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.96426813 |
| 55 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.96128008 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.95766073 |
| 57 | Melanogenesis_Homo sapiens_hsa04916 | 0.94958505 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.94397048 |
| 59 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.93570335 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.93389749 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.92469641 |
| 62 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.89886164 |
| 63 | Phototransduction_Homo sapiens_hsa04744 | 0.88854977 |
| 64 | Retinol metabolism_Homo sapiens_hsa00830 | 0.87186484 |
| 65 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.86825733 |
| 66 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.86366431 |
| 67 | Bile secretion_Homo sapiens_hsa04976 | 0.86126248 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84998343 |
| 69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.83560589 |
| 70 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.82826275 |
| 71 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.82232391 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78055863 |
| 73 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.77489599 |
| 74 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.75985098 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.75115634 |
| 76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.73371777 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72597471 |
| 78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72539181 |
| 79 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.72256997 |
| 80 | Circadian rhythm_Homo sapiens_hsa04710 | 0.72112652 |
| 81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71149424 |
| 82 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70563722 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69611695 |
| 84 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.69422848 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.67844675 |
| 86 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.67279865 |
| 87 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.66066229 |
| 88 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66063315 |
| 89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.64553183 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64391219 |
| 91 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.63786355 |
| 92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.62220039 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61582293 |
| 94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61039191 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60291785 |
| 96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58560153 |
| 97 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.57915915 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57735485 |
| 99 | Adherens junction_Homo sapiens_hsa04520 | 0.56432733 |
| 100 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.55995456 |
| 101 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.55704360 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54121023 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53281138 |
| 104 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53151278 |
| 105 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.52567274 |
| 106 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.52369933 |
| 107 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.51748345 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50064638 |
| 109 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.49108321 |
| 110 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48789141 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48553275 |
| 112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48377922 |
| 113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47071815 |
| 114 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46552612 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46210987 |
| 116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44247253 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44120188 |
| 118 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.44097891 |
| 119 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.43929908 |
| 120 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42893358 |
| 121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41100141 |
| 122 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.39595062 |
| 123 | Endocytosis_Homo sapiens_hsa04144 | 0.37912437 |
| 124 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37871599 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36496762 |
| 126 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35849579 |
| 127 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.34881479 |
| 128 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33785734 |
| 129 | Alcoholism_Homo sapiens_hsa05034 | 0.32893615 |
| 130 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31918635 |
| 131 | Mineral absorption_Homo sapiens_hsa04978 | 0.30783391 |
| 132 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30516491 |
| 133 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30320631 |
| 134 | Prion diseases_Homo sapiens_hsa05020 | 0.28751299 |
| 135 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24887683 |
| 136 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.24324874 |
| 137 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.24265094 |
| 138 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.23429072 |
| 139 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.23151842 |
| 140 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23067200 |

